Interleukin-10 and tumor necrosis factor-alpha: Model of immunomodulation in multiple sclerosis

Neurological Research

Volumn 28, Issue 2, 2006, Pages 193-195

  Perrella, Oreste ^a,d   Sbreglia, Costanza ^a   Perrella, Marco ^b   Spetrini, Giuliano ^c   Gorga, Fernanda ^c   Pezzella, Marianna ^b   Perrella, Alessandro ^b   Atripaldi, Luigi ^a   Carrieri, Pietro ^b  

^a AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d Federico II Medical School University of Naples ^*  (Italy)

Author keywords

CD4+ CD7+ T lymphocytes; IL 10; Multiple sclerosis; TNF

Indexed keywords

CD4 ANTIGEN; CD7 ANTIGEN; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID EXAMINATION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE CONTROL; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; RELAPSE; REMISSION; T LYMPHOCYTE; TH1 CELL;

ADOLESCENT; ADULT; ANTIGENS, CD7; CD4-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN-10; MALE; MIDDLE AGED; MODELS, NEUROLOGICAL; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645785023     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164105X39879     Document Type: Article

References (12)

1. Perrella O, Carrieri PB, De Mercato R, et al. Markers of activated T Lymphocytes and T cell receptor gamma/delta+ in patients with multiple sclerosis. Eur Neurol 1993; 33: 152-155
2. Hoffmann FM, Hinton DR, Johnson K, et al. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989; 170: 607-610
3. Martin R, Mc Farland HF, Mc Farlin DE. Immunological aspects of demyelinating diseases. Ann Rev Immunol 1992; 10: 153-193
4. Powrie F, Coffman RC. Cytokine regulation of T cells function: Potential for therapeutic intervention. Immunol Today 1993; 14: 270-273
5. Poser CM, Paty DW, Schenberg L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-233
6. Abbas AK, Murphy HM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 787-792
7. Olsson T. Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis. Eur J Neurol 1994; 1: 7-12
8. Rott O, Fleischer B, Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 1994; 24: 1434-1438
9. Carrieri PB, Provitera V, Bruno R, et al. Possibile role of transforming growth factor-β in relaping remitting multiple sclerosis. Neurol Res 1997; 19: 599-600
10. Olsson T. Immunology of multiple sclerosis. Cur Opin Neurol Neurosurg 1992; 5: 195-203
11. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997; 18: 263-267
12. Perrella O, Carrieri PB, Perrella A, et al. Transforming growth factor-betal and interferon-alpha in the AIDS demantia complex (ADC): Possible relationship with cerebral viral load? Eur Cytokine Netw 2001; 12: 51-55